BioSpace News Archive

CTI BioPharma Corp. reported its financial results for the fourth quarter and full year ended December 31, 2019.

New Drug Application Rolling Submission for Alagille Syndrome Planned to Begin in Third Quarter 2020

Fourth Quarter DEXTENZA® Net Product Revenue of $1.6 million, a 433% Sequential Increase; Guiding First Quarter Total Net Product Revenue of $3.0 million to $3.2 million

Announced Encouraging Initial Clinical Data From the Phase 1/2 pheNIX PKU Gene Therapy Trial and Expects to Select Dose for Randomized, Concurrently Controlled Expansion Part Mid-Year 2020

MediPines Corporation, in keeping with their mission of advancing respiratory medicine, has released a statement of guidance on the use of the MediPines Gas Exchange Monitor in the monitoring of patients that have symptoms of suspected COVID-19 or other respiratory infections.

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced financial results for the fourth quarter and year ended December 31, 2019.

Walgreens is taking a number of steps in its stores and pharmacies across the U.S., and introducing additional services, to help support customers and patients during the COVID-19 pandemic.

RingMD USA Inc. announced that it will offer a white-labeled version of its telemedicine platform for free to doctors, hospitals, group practices and other healthcare organizations worldwide, in an effort to support and improve industry-wide responsiveness to those who are negatively affected by the COVID-19 crisis.

Dosed the First Patients in the Phase 2b ReNeu Clinical Trial of Mirdametinib for Patients with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas (NF1-PN)

ChromaDex Corp. seeks to correct statements made by an unaffiliated third-party, Merkel Media Group on behalf of its unnamed client, implying unsupported health claims about Tru Niagen and COVID-19.